Aldagen Inc. Names Lyle Hohnke CEO
Aldagen Inc. named Lyle A. Hohnke its chief executive officer to succeed Tom Amick. Hohnke has more than 35 years of experience in the health care industry. He has been a member of The Durham, N.C.-based developer of regenerative therapies since 2008. Aldagen has raised venturce capital funds from firms like Intersouth Partners, Harbert Venture Partners, The Aurora Funds, Tullis-Dickerson and Trelys Funds.
18 October 2010•2 mins read
